HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

De novo mutations in ataxin-2 gene and ALS risk.

Abstract
Pathogenic CAG repeat expansion in the ataxin-2 gene (ATXN2) is the genetic cause of spinocerebellar ataxia type 2 (SCA2). Recently, it has been associated with Parkinsonism and increased genetic risk for amyotrophic lateral sclerosis (ALS). Here we report the association of de novo mutations in ATXN2 with autosomal dominant ALS. These findings support our previous conjectures based on population studies on the role of large normal ATXN2 alleles as the source for new mutations being involved in neurodegenerative pathologies associated with CAG expansions. The de novo mutations expanded from ALS/SCA2 non-risk alleles as proven by meta-analysis method. The ALS risk was associated with SCA2 alleles as well as with intermediate CAG lengths in the ATXN2. Higher risk for ALS was associated with pathogenic CAG repeat as revealed by meta-analysis.
AuthorsJosé Miguel Laffita-Mesa, Jorge Michel Rodríguez Pupo, Raciel Moreno Sera, Yaimee Vázquez Mojena, Vivian Kourí, Leonides Laguna-Salvia, Michael Martínez-Godales, José A Valdevila Figueira, Peter O Bauer, Roberto Rodríguez-Labrada, Yanetza González Zaldívar, Martin Paucar, Per Svenningsson, Luís Velázquez Pérez
JournalPloS one (PLoS One) Vol. 8 Issue 8 Pg. e70560 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID23936447 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ataxins
  • Nerve Tissue Proteins
  • Peptides
  • polyglutamine
Topics
  • Adult
  • Aged
  • Alleles
  • Amyotrophic Lateral Sclerosis (genetics)
  • Ataxins
  • Base Sequence
  • Female
  • Genetic Loci (genetics)
  • Genetic Predisposition to Disease (genetics)
  • Haplotypes (genetics)
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Nerve Tissue Proteins (genetics)
  • Pedigree
  • Peptides (genetics)
  • Repetitive Sequences, Nucleic Acid (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: